Building on the insights from the previous seminar on licensing within the pharmaceutical industry, we delve deeper into the critical processes and vital intellectual property (IP) aspects of in-licensing, due diligence (DD) and mergers & acquisitions (M&A).
• Discover how thorough DD can safeguard your investments
• Learn the intricacies of in-licensing to expand your portfolio
• Explore strategic M&A’s to drive growth
Welcome to an after work event and seminar, where you will hear from experts in the field:
• Tomas Lundquist, Vice President, Head of IP at Sobi
• Ulrika Munter, Senior Patent Counsel at Sobi
• Malcolm Wiberg, Legal Director at Alvotech
The discussion will be moderated by Louise Jonshammar, Partner and Attorney at Law at AWA.
More info and Register
